# | Filing Date | Period End Date | Type | Report Link |
---|---|---|---|---|
No Data found |
# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
This suspension was made because the Company fell below the NYSE's continued listing standard requiring listed companies to...
Shares of bluebird bio, Inc. (NASDAQ: BLUE) rose sharply during Monday’s session after the company presented updated data from ...
Piper Sandler analyst Jason Bednar maintains Vapotherm (NYSE:VAPO) with a Underweight and lowers the price target from $2 to...